Back to Search Start Over

High Magnesium and Sirolimus on Rabbit Vascular Cells—An In Vitro Proof of Concept

Authors :
Fedele, Giorgia
Castiglioni, Sara
Maier, Jeanette A.
Locatelli, Laura
Source :
Materials, Materials, Vol 14, Iss 1970, p 1970 (2021), Volume 14, Issue 8
Publication Year :
2021
Publisher :
MDPI, 2021.

Abstract

Drug-eluting bioresorbable scaffolds represent the last frontier in the field of angioplasty and stenting to treat coronary artery disease, one of the leading causes of morbidity and mortality worldwide. In particular, sirolimus-eluting magnesium-based scaffolds were recently introduced in clinical practice. Magnesium alloys are biocompatible and dissolve in body fluids, thus determining high concentrations of magnesium in the local microenvironment. Since magnesium regulates cell growth, we asked whether high levels of magnesium might interfere with the antiproliferative action of sirolimus. We performed in vitro experiments on rabbit coronary artery endothelial and smooth muscle cells (rCAEC and rSMC, respectively). The cells were treated with sirolimus in the presence of different concentrations of extracellular magnesium. Sirolimus inhibits rCAEC proliferation only in physiological concentrations of magnesium, while high concentrations prevent this effect. On the contrary, high extracellular magnesium does not rescue rSMC growth arrest by sirolimus and accentuates the inhibitory effect of the drug on cell migration. Importantly, sirolimus and magnesium do not impair rSMC response to nitric oxide. If translated into a clinical setting, these results suggest that, in the presence of sirolimus, local increases of magnesium concentration maintain normal endothelial proliferative capacity and function without affecting rSMC growth inhibition and response to vasodilators.

Details

Language :
English
ISSN :
19961944
Volume :
14
Issue :
8
Database :
OpenAIRE
Journal :
Materials
Accession number :
edsair.pmid.dedup....5dcd54c476bd57ea58035037defe05eb